this is complex isn't it? Where does the anti cancer properties of rc220 fit in the current scope of clinical management? Surely not as a traditional chemo drug? So how does an investor evaluate what potential rc220 has when we don't know where it fits in current guidelines.
RAC Price at posting:
$1.39 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)